JPRN-UMIN000022358已完成未知
A study on the effect of combining genetic test and plasma amino acid test on promoting health care actions. - A study on the effect of combining genetic test and plasma amino acid test on promoting health care actions.
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 240
研究概览
简要总结
Combining the genetic testing "MYCODE" and "AminoIndexTM" screening test, based on plasma amino acid profile, raised health consciousness in mind and action compared to having either one of the tests.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 25years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Those who are pregnant, or breast feeding 2)Those who have congenital metabolic disorders 3)Those who are undergoing dialysis 4)Those who are participating in another clinical study 5)Those who have mental diseases or disorders and for whom doctors judged difficult to participate in the study. 6)Those for whom the doctor judged inappropriate to participate in the study.
研究者
相似试验
已完成
不适用
Effectiveness of AI Genetic Counseling Program vs In-person Genetic Counseling in Breast CancerBreast CancerNCT04354675Case Comprehensive Cancer Center35
已完成
不适用
Association Between the Results of Specific Genetic Tests and the Efficacy of Targeted Therapies in PatientsNon-small Cell Lung CancerNCT05450081Hunan Province Tumor Hospital140
终止
4 期
Combinatorial Pharmacogenomics Testing in Treatment-Naïve Major Depressive DisorderDepressive DisorderMajor Depressive DisorderDepressive EpisodeDepression, UnipolarDepressionNCT03537547Washington University School of Medicine6
招募中
不适用
Effects of predictive genetic testingGenetic risk testing for malignancies (e.g., Breast Cancer 1/2), cardiovascular diseases, coagulation (e.g., thrombophilia), storage disorders (e.g., hemochromatosis), cholesterol, glaucoma, and pharmacogenomic informationDRKS00017820Robert Bosch Krankenhaus800
Unknown
不适用
A Study of the Impact of Genetic Testing on Clinical Decision Making and Patient CarePainChronic PainMental DisordersCardiovascular DiseasesArthritisDiabetes Mellitus, Type 2NCT02487888Proove Bioscience, Inc.100,000